Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Feb 2024. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5306313016 | Product containing precisely benzydamine hydrochloride 1.5 milligram/1 milliliter and cetylpyridinium chloride 5 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5306314010 | Benzydamine hydrochloride 1.5 mg/mL and cetylpyridinium chloride 5 mg/mL oromucosal solution | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely benzydamine hydrochloride 1.5 milligram/1 milliliter and cetylpyridinium chloride 5 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | Has manufactured dose form | Oromucosal solution | true | Inferred relationship | Some | ||
Product containing precisely benzydamine hydrochloride 1.5 milligram/1 milliliter and cetylpyridinium chloride 5 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Benzydamine hydrochloride | true | Inferred relationship | Some | 1 | |
Product containing precisely benzydamine hydrochloride 1.5 milligram/1 milliliter and cetylpyridinium chloride 5 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Benzydamine hydrochloride | true | Inferred relationship | Some | 1 | |
Product containing precisely benzydamine hydrochloride 1.5 milligram/1 milliliter and cetylpyridinium chloride 5 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | This attribute specifies the numerator unit for the concentration strength of a product. | mg | true | Inferred relationship | Some | 1 | |
Product containing precisely benzydamine hydrochloride 1.5 milligram/1 milliliter and cetylpyridinium chloride 5 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | This attribute specifies the denominator unit for the concentration strength of a product. | mL | true | Inferred relationship | Some | 1 | |
Product containing precisely benzydamine hydrochloride 1.5 milligram/1 milliliter and cetylpyridinium chloride 5 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Cetylpyridinium chloride (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely benzydamine hydrochloride 1.5 milligram/1 milliliter and cetylpyridinium chloride 5 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Cetylpyridinium chloride (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely benzydamine hydrochloride 1.5 milligram/1 milliliter and cetylpyridinium chloride 5 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | This attribute specifies the numerator unit for the concentration strength of a product. | mg | true | Inferred relationship | Some | 2 | |
Product containing precisely benzydamine hydrochloride 1.5 milligram/1 milliliter and cetylpyridinium chloride 5 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | This attribute specifies the denominator unit for the concentration strength of a product. | mL | true | Inferred relationship | Some | 2 | |
Product containing precisely benzydamine hydrochloride 1.5 milligram/1 milliliter and cetylpyridinium chloride 5 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | Is a | Benzydamine and cetylpyridinium only product in oromucosal dose form | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets